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Dear Editor, 
 
Sulforaphane [SFN: 1-isothiocyanato-4-(methylsulfinyl)butane] belongs to the isothiocy-
anate class of phytochemicals. Glucoraphanin, a glucosinolate precursor of SFN, is a glucos-
inolate found in cruciferous vegetables such as broccoli, cabbage, cauliflower, and kale. All 
glucosinolates are composed of a basic structure consisting of a β-D-thioglucose group, a sul-
fonated oxime group, and an amino acid-derived side chain. Glucosinolates are activated by 
enzyme-dependent hydrolysis to their respective isothiocyanates. SFN (molecular formula 
C6H11NOS2) is the biologically active isothiocyanate produced by the metabolism of glu-
coraphanin by the enzyme myrosinase (Fahey et al., 2015).  
SFN is one of the most frequently studied plant-derived isothiocyanate organosulfur com-
pounds. It has been reported to exhibit a wide range of biological effects including antioxidant 
(Fahey and Talalay, 1999), antimicrobial (Johansson et al., 2008), anticancer (Amjad et al., 
2015), anti-inflammatory (Greaney et al., 2016), anti-aging (Sikdar et al., 2016), neuroprotec-
tive (Tarozzi et al., 2013), and antidiabetic (Lee et al., 2012).  
SFN shows a range of biological activities and health benefits in humans, has been found 
to be a very promising chemopreventive agent against not only a variety of cancers such as 
breast, prostate, colon, skin, lung, stomach, and bladder but also against cardiovascular and 
neurodegenerative diseases and diabetes (Yang et al., 2016). In this present study, we re-
viewed the most recent studies on the biological and pharmacological activities of SFN (Table 
1).  
 
Table 1: Recent studies on biological and pharmacological activities of sulforaphane (SFN) 
Key findings Reference 
The immunomodulatory effects of SFN clearly indicate that it alleviates chronic in-
flammatory diseases by targeting monocytes/macrophages. 
Pal and 
Konkimalla, 2016
SFN attenuates experimental contrast-induced nephropathy in vitro and in vivo. 
This effect is suggested to be mediated by activation of the nuclear factor 
erythroid-derived 2-like 2 (Nrf2) antioxidant defence pathway. 
Zhao et al., 2016 
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Key findings Reference 
SFN inhibited hepatocellular carcinoma cell proliferation in a dose- and time-
dependent manner. All our findings indicate that SFN is a promising and safe 
strategy for treating hepatocellular carcinoma. 
Wu et al., 2016 
SFN treatment increases the liver 3α-hydroxysteroid dehydrogenases, acceler-
ates the degradation of blood dihydrotestosterone (DHT), and subsequently 
blocks the suppression of hair growth by DHT. 
Sasaki et al., 
2016 
The chemopreventive effect of SFN is associated with its inhibition of histone 
deacetylase (HDAC) activity, which attenuates lung cancer growth. These find-
ings suggest that SFN may be a promising therapeutic agent for lung cancer by 
the inhibition of HDAC. 
Jiang et al., 2016 
Treatment with SFN could be useful for improving cognitive function in patients 
with cirrhosis with minimal or clinical hepatic encephalopathy. 
Hernández-
Rabaza et al., 
2016 
The use of SFN as a protective agent against ultraviolet damage is a novel appli-
cation, and it appears to be a very promising emerging ingredient in anti-aging 
drugs and cosmetics. 
Sikdar et al., 
2016 
SFN protects cardiomyocytes from hypoxia/reoxygenation injury in vitro, most 
likely by activating the silent information regulator 1 (Sir1) pathway and subse-
quently inhibiting endoplasmic reticulum (ER) stress-dependent apoptosis. 
Li et al., 2016 
SFN epigenetically stimulates osteoblast activity and diminishes osteoclast bone 
resorption, thereby shifting the bone homeostasis balance to favor bone acquisi-
tion, mitigation of bone resorption, or both in vivo. Thus, SFN is a member of a 
new class of epigenetic compounds that could be considered novel strategies to 
counteract osteoporosis. 
Thaler et al., 
2016 
SFN remarkably suppressed cell growth and enhanced cell death in chemo-
resistant xenografts in the nude mouse model. Collectively, the present study 
suggests that the clinical efficacy of temozolomide-based chemotherapy of te-
mozolomide-resistant glioblastoma may be improved by combination therapy with 
SFN. 
Lan et al., 2016 
SFN ameliorates the progression of high cholesterol diet-induced atherosclerotic 
lesions and vascular dysfunction, possibly via its lipid-lowering and antioxidant ef-
fects and suppression of nuclear factor-kappa B (NF-κB)-mediated inflammation. 
Shehatou and 
Suddek, 2016 
SFN is a beneficial supplement that may be useful for reducing microglial-
mediated neuroinflammation and the oxidative stress associated with aging. 
Townsend and 
Johnson, 2016 
SFN exerts protective effects against lipopolysaccharide-induced acute lung injury 
through the nuclear factor-erythroid 2-related factor 2 (NFE2L2)/antioxidant re-
sponse element (ARE) pathway. Thus, SFN may be a potential candidate for use 
in the treatment of acute lung injury. 
Qi et al., 2016 
The SFN-mediated modification of chromatin composition and structure associat-
ed with target gene expression provides a new mechanism by which dietary phy-
tochemicals may exert their chemopreventive activity. 
Abbas et al., 
2016 
Dietary supplementation with broccoli sprout extract containing the SFN precur-
sor, glucoraphanin, is likely to be highly effective in improving liver function 
through the reduction of oxidative stress. 
Kikuchi et al., 
2015 
Glucoraphanin supplementation for a few weeks is safe but may not be sufficient 
to produce changes in breast tissue tumor biomarkers. Future studies using larger 
sample sizes should evaluate alternative dosage regimens to improve dietary 
SFN strategies for breast cancer chemoprevention. 
Atwell et al., 2015
SFN suppresses the inflammatory response by inhibiting the NF-ĸB signaling 
pathway in a rat model of focal cerebral ischemia and, therefore, may be a poten-
tial therapeutic agent for the treatment of cerebral ischemia injury.  
Ma et al., 2015 
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Key findings Reference 
SFN may inhibit human colon cancer progression and cancer cell angiogenesis 
by inhibiting hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth 
factor (VEGF) expression. Taken together, these results indicate that SFN is a 
new and potent chemopreventive drug candidate for treating patients with human 
colon cancer. 
Kim et al., 2015 
SFN attenuated the cytotoxicity of cadmium selenide (CdSe) quantum dots (QDs) 
in both human hepatocytes and the mouse liver, and this protection was associ-
ated with the induction of the Nrf2 pathway and autophagy. 
Wang et al., 2015
SFN activates DNA methylation-silenced tumor suppressor genes in breast can-
cer cells. Therefore, SFN may be a supportive adjuvant therapy with the anti-
cancer drug, clofarabine and, therefore, might increase its effectiveness in solid 
tumor treatment. 
Lubecka-
Pietruszewska et 
al., 2015 
The potential usefulness of the blockade of bronchoconstrictor hyperresponsive-
ness in some types of asthmatics by phytochemicals such as SFN has been re-
ported. 
Brown et al., 
2015 
The antioxidant effects of SFN in mouse plasma and hippocampal formations is 
evidenced by the increased catalase and superoxide dismutase activity, as well 
as the increased adenosine triphosphate (ATP) production by hippocampal mito-
chondria. Furthermore, these effects likely underlie SFN's anticonvulsant mecha-
nisms of action. 
Carrasco-Pozo et 
al., 2015 
In vehicle-treated mice, ischemia/reperfusion (I/R) injury produced a marked thin-
ning of the inner retinal layers, which, however, appeared to be significantly re-
duced following SFN treatment. Therefore, SFN may be beneficial in the treat-
ment of retinal disorders associated with I/R injury. 
Ambrecht et al., 
2015 
SFN reversed the iron-induced decrease in the mitochondrial fission protein, 
DNM1L, as well as hippocampal synaptophysin levels, leading to a recovery of 
the associated recognition memory impairment. These findings suggest that SFN 
should be further investigated as a potential agent for the treatment of cognitive 
deficits associated with neurodegenerative disorders. 
Lavich et al., 
2015 
SFN does not directly stimulate autophagy or cell death in metastatic prostate 
cancer cells under physiologically relevant conditions. However, it supports the 
involvement of important in vivo effectors that mediate its prostate cancer sup-
pression. 
Waston et al., 
2015 
SFN may have prophylactic and therapeutic effects on cognitive impairment in 
schizophrenia. Therefore, the dietary intake of SFN-rich broccoli sprouts during 
the juvenile and adolescent stage may prevent the onset of adult psychosis. 
Shirai et al., 2015
SFN was also found to efficiently scavenge hydrogen peroxide by converting it in-
to water. Thus, the mechanism of action of SFN as an excellent antioxidant has 
been revealed. 
Prasad and Mish-
ra, 2015 
SFN protected the vascular endothelial cells against lysophosphatidylcholine-
induced injury by enhancing the antioxidative capabilities mediated by Nrf-2 trans-
location. 
Li et al., 2015 
Daily administration of free SFN shows promise in managing biochemical recur-
rences of prostate cancer after radical prostatectomy. 
Cipolla et al., 
2015 
SFN demonstrates pleiotropic behavior, owing to its effects on different cellular 
targets, suggesting a potential role in preventing or counteracting multifactorial 
neurodegenerative disorders such as Alzheimer's disease (AD). 
Angeloni et al., 
2015 
SFN reduced the liver oxidative stress induced by I/R injury. Furthermore, histo-
logical injury of the liver was reduced by SFN administration. However, SFN 
showed no significant effects on the remote organ injuries induced by IR. 
Oguz et al., 2015 
SFN plays a protective role against acetaminophen-mediated hepatotoxicity 
through antioxidant effects mediated by heme oxygenase-1 (HO-1) induction. 
SFN has preventive actions against oxidative stress-mediated liver injury. 
Noh et al., 2015 
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Key findings Reference 
SFN ameliorated experimental diabetic nephropathy, at least in part, via the gly-
cogen synthase kinase 3-beta (GSK3β)/Fyn (tyrosine kinase)/Nrf2 signaling 
pathway. 
Shang et al., 
2015 
Combined treatment of cells with SFN and 3-methyladenine (3-MA) proved to be 
effective in decreasing cell viability, through a mechanism that may involve early 
SFN-induced autophagy, followed by induction of apoptosis and inhibition of au-
tophagy by 3-MA. 
Horwacik et al., 
2015 
SFN showed more potent renoprotection against I/R injury than ischemic precon-
ditioning (Ipre) did, and this effect might involve synergism between them at the 
molecular but not functional level. 
Shokeir et al., 
2015 
SFN stimulates suicidal erythrocyte death or eryptosis, which may, at least partial-
ly, be due to the stimulation of Ca(2+) entry and ceramide formation. 
Alzoubi et al., 
2015 
SFN stimulates proteasome activity and autophagy in normal and Hutchinson-
Gilford progeria syndrome (HGPS) fibroblast cultures. Specifically, SFN enhances 
progerin clearance by autophagy and reverses the phenotypic changes that are 
the hallmarks of HGPS. Therefore, SFN is a promising therapeutic strategy for 
children with HGPS. 
Gabriel et al., 
2015 
SFN has the potential to prevent cardiac hypertrophy by downregulating the tran-
scription factors GATA-binding factor 4/6 (GATA4/6) and mitogen-activated pro-
tein kinase (MAPK) signaling pathways. 
Kee et al., 2015 
Both SFN and klotho, a protein with multiple pleiotropic effects associated with 
anti-aging, enhance the antioxidant defenses, which may protect against vascular 
smooth muscle cell dysfunction in age-related cardiovascular diseases. 
Rizzo et al., 2014
SFN showed protective effects against retinal I/R, which could be attributed, at 
least in part, to the activation of the Nrf2/HO-1 antioxidant pathway. Pan et al., 2014 
SFN alleviates D-galactosamine/lipopolysaccharide-induced liver injury, possibly 
by exerting antioxidant, anti-inflammatory, and antiapoptotic effects and modulat-
ing certain antioxidant defense enzymes. 
Sayed et al., 
2014 
Dietary SFN is recognized to have low toxicity and was identified for its ability to 
reverse abnormalities associated with autism spectrum disorder. The abnormali-
ties included oxidative stress and lowered antioxidant capacity, depressed gluta-
thione synthesis, reduced mitochondrial function and oxidative phosphorylation, 
increased lipid peroxidation, and neuroinflammation. 
Singh et al., 2014
Blockade of the advanced glycation end product (AGE)-receptor for AGE (RAGE) 
axis in pericytes by SFN might be a novel therapeutic target for the treatment of 
diabetic retinopathy. 
Maeda et al., 
2014 
SFN ameliorates neurobehavioral deficits by reducing cholinergic neuron loss in 
the brains of AD-like mice, and the underlying mechanism may be associated with 
neurogenesis and aluminum load reduction. These findings suggest that the phy-
tochemical, SFN has potential usefulness in AD therapy. 
Zhang et al., 
2014 
SFN-enhanced autophagy flux provided protection against prion-mediated neuro-
toxicity, which was regulated by adenosine monophosphate (AMP)-activated pro-
tein kinase (AMPK) signaling pathways in human neuronal cells. This data also 
suggests that SFN has potential value as a therapeutic tool in neurodegenerative 
disorders including prion diseases. 
Lee et al., 2014 
SFN might set the stage for the development of a novel therapeutic principle that 
complements the growing armature against malignancies, which would encour-
age the exploration of its efficacy in a broader population of patients with leuke-
mia. 
Fimognari et al., 
2014 
SFN has antitumor effects against bladder cancer cells mediated through a reac-
tive oxygen species (ROS)-mediated intrinsic apoptotic pathway, which suggest 
that ER stress and Nrf2 may represent strategic targets for SFN-induced apopto-
sis. 
Jo et al., 2014 
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